Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance Immediately
- Status
- COMPLETED
- Phase
- PHASE1
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- Status
- RECRUITING
- Phase
- PHASE1
Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)
- Status
- COMPLETED
- Phase
- PHASE3
CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cabozantinib and Pembrolizumab in Metastatic Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Longer-Acting PrEP in Transgender and Gender Diverse Texans
- Status
- COMPLETED
- Phase
- N/A
Letermovir for CMV Prevention After Lung Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)
- Status
- TERMINATED
- Phase
- PHASE1